During the last session, Axogen Inc (NASDAQ:AXGN)’s traded shares were 1.13 million, with the beta value of the company hitting 0.98. At the end of the trading day, the stock’s price was $12.05, reflecting an intraday gain of 2.47% or $0.29. The 52-week high for the AXGN share is $21.00, that puts it down -74.27 from that peak though still a striking 39.09% gain since the share price plummeted to a 52-week low of $7.34. The company’s market capitalization is $548.81M, and the average intraday trading volume over the past 10 days was 0.94 million shares, and the average trade volume was 641.09K shares over the past three months.
Axogen Inc (AXGN) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.12. AXGN has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be 0.06.
Axogen Inc (NASDAQ:AXGN) trade information
Axogen Inc (AXGN) registered a 2.47% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 2.47% in intraday trading to $12.05, hitting a weekly high. The stock’s 5-day price performance is 8.95%, and it has moved by 15.75% in 30 days. Based on these gigs, the overall price performance for the year is -26.88%. The short interest in Axogen Inc (NASDAQ:AXGN) is 2.27 million shares and it means that shorts have 3.72 day(s) to cover.
Axogen Inc (AXGN) estimates and forecasts
In the rating firms’ projections, revenue will increase 15.40% compared to the previous financial year.
As companies strive to predict their financial trajectories, we turn our attention to the forthcoming financial quarter. Here are the insights gathered from industry analysts. Revenue for the current quarter is expected to be 52.61M as predicted by 7 analyst(s). Meanwhile, a consensus of 7 analyst(s) estimates revenue growth to 56.16M by the end of current fiscal year. As per earnings report from last fiscal year’s results, sales for the corresponding quarters totaled 47.91M and 48.64M respectively. In this case, analysts expect current quarter sales to grow by 9.80% and then jump by 15.44% in the coming quarter.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 21.24%. While earnings are projected to return 60.71% in 2025, the next five years will return 86.26% per annum.
AXGN Dividends
Axogen Inc is due to release its next quarterly earnings on 2025-May-08. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Axogen Inc (NASDAQ:AXGN)’s Major holders
Axogen Inc insiders own 4.84% of total outstanding shares while institutional holders control 86.20%, with the float percentage being 90.58%. ARROWMARK COLORADO HOLDINGS LLC is the largest shareholder of the company, while 250.0 institutions own stock in it. As of 2024-06-30, the company held over 5.12 million shares (or 11.7048% of all shares), a total value of $37.04 million in shares.
The next largest institutional holding, with 3.34 million shares, is of FIRST LIGHT ASSET MANAGEMENT, LLC’s that is approximately 7.6499% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $24.21 million.
Also, the Mutual Funds coming in first place with the largest holdings of Axogen Inc (AXGN) shares are VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF . Data provided on Mar 31, 2025 indicates that VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund owns about 1.31 shares. This amounts to just over 2.88 percent of the company’s overall shares, with a $15.78 million market value. The same data shows that the other fund manager holds slightly less at 1.08, or about 2.36% of the stock, which is worth about $12.97 million.
